Samsung Biologics has appointed John Rim as its president and chief executive officer. The appointment was made effective immediately and formalized via the company’s board of directors meeting today.   Prior to being appointed CEO, Mr. Rim served as executive vice president at Samsung Biologics for the past three years and was a key senior leadership contributor in driving the company’s success through a strong focus on client satisfaction and global business acumen. He was also instrumental in...